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Available online 28 September 2014Abstract Although adult cardiomyocytes have the capacity for cellular regeneration, they are unable to fully repair severely
injured hearts. The use of embryonic stem cell (ESC)-derived cardiomyocytes as transplantable heart muscle cells has been
proposed as a solution, but is limited by the lack of understanding of the developmental pathways leading to specification of
cardiac progenitors. Identification of these pathways will enhance the ability to differentiate cardiomyocytes into a clinical
source of transplantable cells. Here, we show that the mRNA 3′ end processing protein, CstF-64, is essential for cardiomyocyte
differentiation in mouse ESCs. Loss of CstF-64 in mouse ESCs results in loss of differentiation potential toward the endodermal
lineage. However, CstF-64 knockout (Cstf2E6) cells were able to differentiate into neuronal progenitors, demonstrating that
some differentiation pathways were still intact. Markers for mesodermal differentiation were also present, although Cstf2E6
cells were defective in forming beating cardiomyocytes and expressing cardiac specific markers. Since the extraembryonic
endoderm is needed for cardiomyocyte differentiation and endodermal markers were decreased, we hypothesized that
endodermal factors were required for efficient cardiomyocyte formation in the Cstf2E6 cells. Using conditioned medium from
the extraembryonic endodermal (XEN) stem cell line we were able to restore cardiomyocyte differentiation in Cstf2E6 cells,
suggesting that CstF-64 has a role in regulating endoderm differentiation that is necessary for cardiac specification and that
extraembryonic endoderm signaling is essential for cardiomyocyte development.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Embryonic stem cell (ESC) derived cardiomyocytes offer a
source of transplantable heart cells (Passier et al., 2008; Segers
and Lee, 2008; Chong et al., 2014), but the developmental and⁎ Corresponding author. Fax: +1 806 743 2990.
E-mail address: clint.macdonald@ttuhsc.edu (C.C. MacDonald).
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).molecular pathways leading to specification of cardiac
progenitors remain unclear. In vertebrates, the heart is the
first organ to become functional after gastrulation. For this
process, the primitive endoderm must be present to promote
specification of the nascent mesoderm into cardiomyocytes
(Murry and Keller, 2008; Pauklin et al., 2011). This process can
be mimicked in vitro either by co-culture of ESCs with
endodermal cell lines (Mummery et al., 1991, 2002, 2003) or
by addition of conditioned media from various primitiven access article under the CC BY-NC-ND license
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have elucidated the role of the endoderm in cardiomyocyte
differentiation (Cai et al., 2013). Our interests here are to
understand the role of RNA processing in controlling the
cardiogenic factors required to enable differentiation of
ESC-derived cardiomyocytes.
CstF-64 is the RNA-binding component of the cleavage
stimulation factor (CstF) that is necessary for efficient and
accurate polyadenylation of most mRNAs (Takagaki et al., 1990;
Salisbury et al., 2006; Hockert et al., 2010; Darmon and Lutz,
2012; Tian and Manley, 2013). As such, CstF-64 is involved in the
expression of many cellular mRNAs (Takagaki et al., 1996;
Martin et al., 2012; Yao et al., 2012) including mRNAs encoding
replication-dependent histones (Kolev and Steitz, 2005; Sullivan
et al., 2009; Sabath et al., 2013; Yang et al., 2013). Previously,
we showed that CstF-64 was necessary for correct histone
mRNA 3′ end processing as well as maintenance of pluripotency
in mouse ESCs (Youngblood et al., 2014). CstF-64 knockout ESCs
(Cstf2E6 cells) displayed decreased expression of pluripotency
markers and partial differentiation toward ectodermal and
endodermal lineages. Wild type ESCs and Cstf2E6 cells also
express the mammalian paralog of CstF-64, τCstF-64, which is
necessary for spermatogenesis (Dass et al., 2001, 2002, 2007; Li
et al., 2012). Increased expression of τCstF-64 in Cstf2E6 cells
probably accounted for their viability in the absence of CstF-64
(Youngblood et al., 2014).
In the Cstf2E6 cells, loss of CstF-64 reduced pluri-
potency and led to partial differentiation in ESCs
(Youngblood et al., 2014). Therefore, we wondered
whether CstF-64 was also required for differentiation of
ESCs to other cell lineages including endoderm, ecto-
derm, and mesoderm (Chambers and Smith, 2004;
Chambers and Tomlinson, 2009). Here we demonstrate
that CstF-64 is needed for proper differentiation of mouse
ESCs into the endodermal lineage, but not into ectodermal
or mesodermal endpoints; and that endoderm is required
for further differentiation of mesoderm into cardiomyocyte
cells. Cstf2E6 cells, when differentiated into embryoid
bodies (EBs), displayed a defect in cavitation and a
decrease in both primitive and definitive endoderm
markers, suggesting disruption of endoderm differentia-
tion. However, both mesoderm and ectoderm markers
were expressed normally. In agreement with the EB data,
Cstf2E6 cells were capable of differentiating into neuro-
nal progenitors (an ectodermal lineage). However, in
contrast to their expression of mesodermal markers, Cstf2E6
cells displayed a profound defect in cardiomyocyte differenti-
ation, showing a significant decrease in spontaneous beating
and expression of cardiac markers. To account for this, we
determined that endoderm differentiation was severely
disrupted in the Cstf2E6 cardiomyocytes, although meso-
derm markers were increased. However, we were able to
rescue the spontaneous beating and expression of cardiac
markers in the Cstf2E6 cardiomyocytes through the addition
of conditioned medium from extraembryonic endodermal
(XEN) stem cells, demonstrating that mesodermal and
post-mesodermal potential of the cells was normal. These
data support a necessary role for the primitive endoderm in
ESC-derived cardiomyocyte differentiation and suggest that
CstF-64 is needed for cardiomyocyte differentiation
through the expression of paracrine factors that regulate
endoderm differentiation.Materials and methods
Cell culture
The Cstf2Gt(IST10905E6)Tigm cell line, herein called Cstf2E6
cells, was obtained from Texas A&M Institute for Genomic
Medicine (TIGM) and derived from mouse C57BL/6N-derived
Lex3.13 ESC lines in which a gene-trap cassette was inserted
between the first and second exons (Cstf2Gt(IST10905E6)Tigm,
Youngblood et al., 2014). Mouse embryonic stem cells (ESCs)
were maintained on 0.1% gelatin-coated 10 cm dishes without
feeder cells in Embryo Max DMEM (Millipore) supplemented
with 15% ESC-qualified fetal bovine serum (Hyclone/Thermo),
2 mM L-glutamine (Gibco), 0.1 mM-mercaptoethanol (Sigma),
0.1 mM MEM non-essential amino acid stock (Gibco), and
10 ng/mL human leukemia inhibitory factor (LIF, InVitria).
ESCs were grown at 37 °C in a humidified incubator in 5% CO2
and passaged every two days (~70–80% confluency).
XEN cells (Brown et al., 2010) were a gift from Ann C.
Foley (Clemson University), and were cultured in 10 cm
dishes in ESC complete media without LIF at 37 °C in a
humidified incubator in 5% CO2. For cardiomyocyte differ-
entiation, XEN complete media were obtained from 70%
confluent cells and 0.2 micron-filtered.
Embryoid body differentiation
ESCs were deprived of LIF in complete media for 96 h in 10 cm
dishes. After 96 h, 2 × 106 cells were plated in ultra
low-attachment 10 cm dishes (Corning) for 5, 10, or 15 days
in complete ESC media without LIF.
Neuronal differentiation
N2B27 protocol
Wild type and Cstf2E6 cells were plated on 0.1% gelatin-
coated 6-well plates in N2B27 media (19 mL DMEM/F12
Glutamax medium (Invitrogen), 19 mL neurobasal medium
(Invitrogen), 0.4 mL 100× N2 (Invitrogen), and 0.8 mL 50× B27
(Invitrogen) (Ying et al., 2003)) at 10,000 cells/cm2. Cells
were cultured in N2B27 media for 6 days, followed by RNA
extraction.
4−/4+ protocol
Wild type and Cstf2E6 cells were plated as hanging drop
embryoid bodies in 10 cmdishes in complete ESCmediawithout
LIF (Bain et al., 1995). Briefly, approximately 200 cells/drop
were plated for 24 h, followed by plating in ultra low-
attachment 10 cm dishes (Corning) for 8 days. On the first
4 days, EBs were cultured in complete ESC media without LIF,
followed by the addition of 5 × 10−7 M all-trans retinoic acid
(Sigma) for the last 4 days. After 8 days, the EBs were plated on
laminin (Sigma)-coated dishes for 6 days in ESC completemedia
without LIF, followed by photography and RNA extraction.
Cardiomyocyte differentiation
ESCs were plated as hanging drop EBs in complete ESC media
without LIF for 5 days. After 5 days, EBs were plated in 0.1%
gelatin coated dishes for indicated times. Incidence of
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spontaneous beating. Statistical significance of beating
frequency was determined by counting 3 biological repli-
cates. Cardiomyocyte differentiation with the XEN condi-
tioned media was performed according to Brown et al.
(2010). Briefly, hanging drop EBs were formed and incubated
for 24 h, followed by plating on 0.1% gelatin-coated dishes in
complete ESC media without LIF. XEN media was added on
days 4–6, followed by the addition of complete ESC media
without LIF for the duration of differentiation.RNA extraction
RNA was extracted from ESCs using the Qiagen RNAeasy kit
following the manufacturer's instructions. Genomic DNA was
eliminated using gDNA spin columns provided in the Qiagen
RNAeasy kit. The quantity of RNA was determined using a
NanoDrop device.RT-PCR
Complementary DNA was prepared from total mouse ESC
RNA by reverse transcription with Super Script II RT (Life
Technologies) following the protocol recommended by the
manufacturer. cDNA was amplified using 2× EmeraldAMP PCR
Master Mix (Clonetech) with 30 cycles of 95 °C for 30 s,
55 °C for 30 s, 72 °C for 45 s, and a final extension of 10 min
at 72 °C. For negative −RT control, Super Script II was not
added to cDNA synthesis reaction. PCR products were
displayed on 1.5% agarose (Invitrogen) gels stained with
ethidium bromide (0.5 μg/mL). Primers used in this study
are listed in Supplemental Table 1.Real-time RT-PCR
For real-time PCR, 20 ng of cDNA was amplified in triplicates
using 2× SYBR Green Master Mix (Invitrogen). The PCR
program consisted of 95 °C for 10 min, 40 cycles of 95 °C
for 15 s followed by 55 °C for 1 min. The ribosomal protein
S2 (Rps2) served as a loading control and reference gene.
Relative expression was calculated using the comparative Ct
method as described previously (Youngblood et al., 2014).
Statistical significance was determined using a two-tailed t
test comparing WT and Cstf2E6 cells.Western blots
For Western blots, protein extracts were prepared as
previously described (Youngblood et al., 2014). Briefly,
protein was extracted using RIPA buffer (50 mM Tris–HCl
pH 8.8, 150 mM NaCl, 0.1% SDS, 0.5% deoxycholate, and 0.5%
NP-40) and the concentrations quantified using BCA assay
(Thermo). Proteins were resolved on 10% SDS-polyacrylamide
gels and transferred to PVDF (Millipore) for immunoblot
detection. Primary antibodies for all the polyadenylation
proteins were purchased from Bethyl Laboratories (Montgom-
ery, TX) with the exception of anti-CstF-64 (3A7) and
anti-τCstF-64 (6A9), which were used as previously described
(Wallace et al., 1999).Results
CstF-64 and τCstF-64 are downregulated during in
vitro differentiation
Cstf2E6 cells are C57BL/6N-derived Lex3.13 mouse ESCs that
have a gene trap cassette inserted between the first and
second exons of Cstf2 (Fig. 1A), and thus do not express
detectable CstF-64 (Youngblood et al., 2014). Cstf2E6 cells
have lost pluripotency markers and display characteristics of
partially differentiated cells (ibid.). Thus, we were curious
how these cells responded to differentiation signals. We
induced wild type ESCs and Cstf2E6 cells to differentiate into
embryoid bodies (EBs, see Materials and methods) and
examined the expression of CstF-64 and other polyadenylation
factors. In wild type EBs, CstF-64 and τCstF-64 expression
seemed to decrease after 15 days of differentiation (Fig. 1B,
lanes 1, 3, 5, and 7). In the Cstf2E6 EBs, τCstF-64 expression
was consistently increased compared to wild type (lanes 2, 4,
6, and 8), possibly due to a compensatory mechanism that is
activated upon CstF-64 depletion (Youngblood et al., 2014;
Ruepp et al., 2011; Yao et al., 2013). We also examined
CstF-77 and CPSF-100 protein expression, which was un-
changed between WT and Cstf2E6 cells at all time points
(Fig. 1B). These data suggest that both CstF-64 and τCstF-64
respond independently to differentiation signals, while
other polyadenylation factors are unaffected; the other
polyadenylation factors also do not respond to loss of CstF-64.
This is consistent with our previous observation that these
proteins did not change in CstfE6 cells (Youngblood et al.,
2014).
Cstf2E6 embryoid bodies do not cavitate
EBs are capable of differentiating into derivatives of all
three germ layers (Murry and Keller, 2008; Pauklin et al.,
2011). Upon removal of leukemia inhibitory factor (LIF) and
growth as either hanging drop or in suspension culture, ESCs
form aggregates that mimic mammalian pregastrulation devel-
opment and early gastrulation stages (Murray and Edgar, 2001).
The primitive endoderm, specifically the visceral endoderm
gives rise to a fluid-filled cavity that is essential for proper
gastrulation. To examine the differentiation potential of
the Cstf2E6 cells, we performed embryoid body in vitro
differentiation experiments. Interestingly, the Cstf2E6 EBs
did not form cavities (Fig. 1D), as did wild type EBs (Fig. 1C).
Lack of cavitation suggested a defect in primitive endoderm
differentiation (Coucouvanis and Martin, 1999). To further
verify endoderm disruption in the Cstf2E6 EBs, we per-
formed qRT-PCR on markers for all three germ layers and
markers representing pluripotency. Consistent with the lack
of cavitation observed, the Cstf2E6 EBs displayed significant
reduction of endodermal markers compared to wild type EBs,
including the primitive endoderm marker, Afp, and the
endoderm markers Foxa2 and Sox17 (Figs. 1E–G). In contrast,
themesodermalmarkers,Hand1,Mixl1,Msx1 and the primitive
streak marker, Eomes were significantly increased in the
Cstf2E6 EBs (Figs. 1H–J). However, the hemato-cardiovascular
marker, Flk1 was significantly increased in the wild type EBs
compared to the Cstf2E6 EBs (Supplemental Table 2). In
addition, expression of some of these markers, e.g., Mixl1
Figure 1 Loss of CstF-64 alters ESC differentiation patterns. (A) Schematic representation of insertion of the gene-trap
β-galactosidase-neomycin (Bgeo) fusion protein in the first (Cstf2E6) intron of the Cstf2 gene in the ESC line (Youngblood et al., 2014). The
gene-trap consists of a splice acceptor (SA) site and polyadenylation (PA) signal. Yellow bars represent the open reading frame of Cstf2
mRNA. (B)Western blot analysis shows that Cstf2E6 cells do not express detectable CstF-64 protein either when grown in the presence of LIF
(lane 2) or in the absence of LIF for up to 15 days (lanes 4, 6, and 8). Lanes 1, 3, 5, and 7 are identically treated wild type cells. Also shown
are protein expression levels of τCstF-64, CPSF-100, CstF-77, and β-tubulin. Photomicrographs (100× magnification) of wild type embryoid
bodies (C) or Cstf2E6 cells treated by the same protocol (D). Note the cavity formed in wild type embryoid bodies (arrow in C) that is absent
in Cstf2E6 cells (arrow in D). (E–M) Relative mRNA expression (qRT-PCR) of markers for endoderm (Afp, Foxa2, and Sox17, E, F, and G),
mesoderm (Hand1, Mixl1 and Msx1 H, I, and J), or ectoderm (Fgf8, NCAD and Nes, K, L, and M) in wild type ESCs or EBs (orange bars) and
Cstf2E6 cells (blue bars). ** denotes p b 0.01. Bars indicate standard deviation of at least three biological replicates.
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al., 2005; Lim et al., 2009). This may reflect impaired
differentiation or delay in mesoderm formation. Ectoderm
markers did not show a consistent expression pattern between
the Cstf2E6 and wild type EBs (Figs. 1K–M).
The pluripotency markers Nanog and Klf4 displayed
decreased expression in the wild type EBs, consistent with
the activation of differentiation transcriptional programs
(Supplemental Table 2). Interestingly, Nanog displayed in-
creased expression in the Cstf2E6 EBs on day 15, whereas Klf4
followed a similar pattern to wild type EBs. This increased
expression of Nanog is consistent with the lack of endoderm
differentiation (Hamazaki et al., 2004). These data suggest
that the Cstf2E6 EBs have a defect in endodermal lineage
expression, consistent with their lack of cavitation, but have
higher mesodermal characteristics. Ectoderm lineage markers
are only partially affected.CstF-64 is not necessary for in vitro
neuronal differentiation
To further test the differentiation potential, we subjected
wild type ESCs and Cstf2E6 cells to either the N2B27 or the4−/4+ protocol to differentiate them into neuronal progen-
itors. N2B27 is a chemically defined serum free media that
only allows neuronal progenitors to proliferate in a monolayer
(Ying et al., 2003), whereas the 4−/4+ protocol requires
embryoid body formation and retinoic acid supplementation
followed by laminin attachment (Bain et al., 1995). Both wild
type ESCs and Cstf2E6 cells seemed competent to differentiate
into morphologically neuronal cell types (Figs. 2A, B). We
further performed RT-PCR and qRT-PCR on neuronal markers
Blbp and Mash1 (Fig. 2C and Supplemental Table 3). Wild type
ESC- and Cstf2E6 cell-derived neuronal progenitors demonstrat-
ed increased expression of both Blbp and Mash1 mRNAs using
both protocols, with the 4−/4+ protocol inducing a greater
increase (Fig. 2C). These data suggest that CstF-64 is not
necessary for in vitro differentiation of ESCs into the neuronal
lineage, possibly due to the functional redundancy of τCstF-64.Cstf2E6 cells are unable to form
beating cardiomyocytes
Cardiomyocytes, while of mesodermal origin, require para-
crine factors from endoderm for early specification (Brown
et al., 2010). Although mesodermal markers were increased
Figure 2 Cstf2E6 cells are able to differentiate into neuronal
cells in vitro. Wild type ESCs (A) and Cstf2E6 cells (B) were
differentiated using the 4−/4+ protocol for 14 days. Both cell
types form indistinguishable neurite structures (A and B). (C)
Agarose gel electrophoresis of RT-PCR amplimers made using
RNA from wild type (lanes 1–3) or Cstf2E6 cells (lanes 4–6). Cells
were either grown in the presence of LIF (lanes 1 and 4), or
subjected to differentiation using N2B27 medium (lanes 2 and 5)
or using the 4−/4+ protocol (lanes 3 and 6). Primers were
directed against mouse neuronal markers Blbp or Mash1, or Rps2
as a loading control.
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were significantly decreased relative to wild type (Figs.
1E–G). Therefore, we wondered whether the Cstf2E6 cells
were capable of differentiation to cardiomyocytes, a
mesoderm-derived cell type. We subjected both wild type
ESCs and Cstf2E6 cells to a cardiomyocyte differentiation
protocol (Maltsev et al., 1994) and counted the number of
EBs that demonstrated spontaneous beating on days 8, 10,
and 12. Wild type ESC-derived cardiomyocytes demonstrat-
ed 65–75% beating EBs for all three days, indicating
efficient cardiomyocyte differentiation (Fig. 3A). In con-
trast, the Cstf2E6 ESC derived cardiomyocytes demonstrat-
ed very little spontaneous beating, with only 2–5% EBs
displaying beating (Fig. 3A). In wild type ESCs, CstF-64
levels decreased at day 10 of the cardiomyocyte differen-
tiation protocol, then increased slightly at day 15 (Supple-
mental Fig. 1, lanes 1, 3, and 5). τCstF-64 decreased at both
10 and 15 days of the protocol (lanes 1, 3, and 5), but
increased at day 10 in the Cstf2E6 cells (lanes 2, 4, and 6).
CstF-77 did not appear to change throughout the protocol.
Consistent with the lack of rhythmic beating, the Cstf2E6
cells displayed significantly reduced cardiac markers (Myl2,
Myh6, Myh7, Myl7, and Actc1), significantly higher meso-
dermal markers (Msx1, Hand1, and Mixl1), and significantly
decreased primitive and definitive endodermal markers
(Afp, Ttr, Foxa2, Sox17, and Gata4) compared to wild type
cells (Figs. 3B, C, and Supplemental Fig. 2). In addition,
expression of the transcription factor EomesmRNA in Cstf2E6cardiomyocytes was delayed compared to wild type
cardiomyocytes (Fig. 3B). Consistent with Eomes role in
activating Mesp1 expression to specify the cardiac mesoderm
(Costello et al., 2011), Mesp1 expression also demonstrated a
delayed pattern in Cstf2E6 cardiomyocytes (Fig. 3B). These
data demonstrate that Cstf2E6 cells are impaired in cardio-
myocyte differentiation, though not in mesoderm differenti-
ation. They further suggest that the impairment is due to a
disruption in endoderm signals and not due to defective
mesoderm differentiation.
Cstf2E6 cardiomyocyte potential can be rescued
using XEN cell-conditioned media
Extraembryonic endoderm XEN stem cells are derived from
late blastocyst stage embryos and serve as a developmen-
tally relevant source of primitive endoderm factors (Brown
et al., 2010). To examine whether defective primitive
endoderm differentiation led to cardiomyocyte disruption
in Cstf2E6 cells, we used medium that had been conditioned
by XEN stem cells to promote cardiomyocyte differentiation.
Wild type and Cstf2E6 cells were subjected to the
cardiomyocyte differentiation protocol using either ESC
medium without LIF or XEN cell-conditioned medium. As
before, Cstf2E6 cells formed few beating cardiomyocytes
compared to wild type ESCs (Fig. 4A). Addition of XEN media
to wild type cardiomyocytes did not significantly change
the beating efficiency. However, the addition of XEN
cell-conditioned media on days 4–6 of differentiation almost
completely rescued the ability of the Cstf2E6 cells to form
beating cardiomyocytes, with approximately 65% of EBs
displaying beating (Fig. 4A). Consistent with the increase in
beating incidence, there was an increase in the expression of
mRNAs encoding the cardiac markers, Myh7, Myl2, and Actc1
in the Cstf2E6 XEN medium treated cells compared to the
non-treated cells (Fig. 4B). Addition of XEN cell-conditioned
medium to the Cstf2E6 cardiomyocytes decreased the
expression of the mesoderm marker Mixl1 relative to
non-treated Cstf2E6 cells. In addition, there was an increase
in the expression of the primitive endoderm marker Afp in
the Cstf2E6 XEN-treated cells compared to the non-treated
cells. These data demonstrate that the cardiomyocyte
differentiation potential in Cstf2E6 cells can be rescued
using conditioned media from the XEN cells, suggesting
that endoderm-derived paracrine factors are sufficient to
promote cardiomyogenesis in these cells. Further, they
demonstrate that CstF-64 is necessary for proper endoderm
differentiation that is necessary to specify cardiac progenitors
for efficient cardiomyocyte differentiation, but that CstF-64 is
not otherwise necessary for differentiation to the mesoderm
lineage or cardiomyocytes.
Discussion
The use of stem cell-derived cardiomyocytes is an appealing
approach for treating heart disease (Passier et al., 2008;
Segers and Lee, 2008), but it has not yet demonstrated
clinical success in humans (Chong et al., 2014). However,
before it can be used in regenerative medicine, an efficient
and reproducible cardiomyocyte differentiation protocol
must be established, requiring a molecular investigation
Figure 3 Loss of CstF-64 impairs cardiomyocyte differentiation. (A) Incidence of beating (percent) of wild type (orange) and Cstf2E6
(blue) cardiomyocytes on days 8, 10, and 12 of differentiation. *** denotes p b 0.001. Bars indicate standard deviation of at least
three biological replicates. (B) Agarose gel electrophoresis of RT-PCR amplimers made with RNA from wild type (lanes 1–3) or Cstf2E6
cells (lanes 4–6). Cells were either grown in the presence of LIF (lanes 1 and 4) or differentiated into cardiomyocytes (lanes 2–3 and
5–6). Primers were directed against cardiac (Myl2, Myh6, Myh7, Myl7, and Mesp1), endoderm (Afp, Ttr, and Eomes), and mesoderm
(Msx1, Hand1, and Mixl1) markers. (C) Table displaying the relative mRNA fold change of cardiac, endoderm, and mesoderm genes
acquired from qRT-PCR in wild type and Cstf2E6 day 15 cardiomyocytes. Fold change is relative to wild type cardiomyocytes on day 15.
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require inductive signals from the primitive endoderm
to specify the nascentmesoderm into the cardiac fate. However
these cardiogenic signals have not all been identified. Here we
demonstrate that the mRNA 3′ end processing factor, CstF-64 is
required for differentiation of mouse ESCs into endoderm,
which in turn produces signals necessary to support cardiomyo-
cyte formation. EB-differentiated Cstf2E6 cells display signifi-
cant defects in both primitive and definitive endoderm
expression compared to EB-differentiated wild type ESCs
(Murray and Edgar, 2001), for example, failing to form interior
cavities as do wild type ESCs (Fig. 1). Interestingly, the
endodermal differentiation defect was specific, as neither
mesodermal nor ectodermal lineage expression markers
were significantly reduced in Cstf2E6 cells. Using two
different differentiation protocols, we were able to induce
neuronal differentiation in Cstf2E6 cells (Fig. 2), demon-
strating that specification of mouse ESCs to the neuronal
pathway can progress without CstF-64. While it is somewhat
surprising that this differentiation pathway continues to
function in the absence of CstF-64 (Youngblood et al.,
2014), it is likely that many functions of CstF-64 are
subsumed by τCstF-64 in mammals (Youngblood et al.,
2014; Dass et al., 2007; Yao et al., 2013). Therefore, wepresume that retinoic acid- and sonic hedgehog-dependent
signaling pathways continue to function in Cstf2E6 cells
(Wichterle et al., 2002).
On the other hand, Cstf2E6 cells displayed significant
defects in cardiomyocyte differentiation demonstrated by
the decrease in spontaneous beating and the decrease in
cardiac and endoderm markers compared to wild type ESCs
(Fig. 3). However, the majority of mesoderm markers were
significantly increased, suggesting that mesoderm precur-
sors to cardiomyocytes were not dependent on CstF-64. In
contrast to the other mesodermal markers, Flk1 expression
was increased in wild type EBs (Supplemental Table 2). Flk1
positive cells give rise to cardiovascular cell lineages and
may explain the decreased expression displayed by the
Cstf2E6 EBs compared to wild type (Ishitobi et al., 2011). To
implicate endoderm differentiation disruption in the block
to cardiomyocyte differentiation in the Cstf2E6 cells, we
used conditioned media from the XEN endodermal stem
cell line (Brown et al., 2010) that almost completely rescued
cardiomyocyte beating potential in the Cstf2E6 cells and
resulted in a significant increase in cardiac and endoderm
markers (Fig. 4). This suggests that CstF-64 regulates
the expression of paracrine factors inducing endoderm
differentiation required for cardiomyocyte differentiation.
Figure 4 XEN cell-conditioned medium can rescue the cardiac differentiation defect in Cstf2E6 cells. (A) Graph displaying the
beating incidences of wild type cardiomyocytes (WT), wild type cardiomyocytes grown in the presence of XEN cell-conditioned
medium (WT + XEN), Cstf2E6 cardiomyocytes (E6), and Cstf2E6 cardiomyocytes grown in the presence of XEN cell-conditioned medium
(E6 + XEN) on days 8 and 10 of differentiation. *** denotes p b 0.001. Bars indicate standard deviation of three biological replicates.
(B) Agarose gel electrophoresis of RT-PCR amplimers made with RNA from wild type ESCs (lanes 1), Cstf2E6 cells (lanes 2), wild type
ESCs treated with XEN cell-conditioned medium (lanes 3), or Cstf2E6 cells treated with XEN cell-conditioned medium on day 10 of
cardiomyocyte differentiation. Primers were directed against cardiac (Myl2, Myh7, and Actc1), endoderm (Afp), or mesoderm (Mixl1)
markers. (C) Cartoon depiction of cell lineages and the role of CstF-64 in cardiomyocyte differentiation. In wild type ESCs (left),
embryoid bodies give rise to both the mesoderm cell lineage that can further differentiate to cardiomyocytes and the endoderm cell
lineage that is needed to provide paracrine factors necessary for cardiomyocyte differentiation. Like wild type ESCs, Cstf2E6 cells
lacking CstF-64 (right) differentiate into embryoid bodies that give rise to mesoderm cell lineages. However, CstF-64 is required for
differentiation of ESCs to endoderm. Thus, lacking endoderm-supplied paracrine factors, Cstf2E6 cells fail to differentiate completely
to cardiomyocytes. Addition of XEN cell-conditioned medium can rescue cardiomyocyte differentiation of Cstf2E6 cells by activating
endoderm signaling required for proper cardiomyocyte differentiation.
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and other downregulated genes (Figs. 3B, C), and other CstF-
64-regulated genes such as bone morphogenic protein 2
(BMP2, Liu et al., 2008), which has been previously been
implicated in cardiac fate specification (Monzen et al., 1999;
van Wijk et al., 2007). We propose that CstF-64 regulates
the expression of several of these genes directly through
polyadenylation, resulting in regulation of paracrine path-
ways in endoderm cells necessary to support differentiation
of ESCs into cardiomyocytes.
Previously, CstF-64 expression was shown to increase in
embryonic development as well as in the reprogramming of
somatic cells into iPS cells (Ji et al., 2009; Ji and Tian, 2009).
In contrast, we show here that both CstF-64 and τCstF-64decrease upon differentiation of ESCs into EBs, while other
polyadenylation factors do not (Fig. 1). The CstF-64 mRNA 3′
end-processing factor is involved in both polyadenylation
(Takagaki et al., 1990; Hockert et al., 2010) and replication-
dependent histone mRNA processing (Kolev and Steitz, 2005;
Sabath et al., 2013; Yang et al., 2013; Youngblood et al., 2014).
Changes in both these processes result in changes to
pluripotency, cell cycle and growth characteristics of mouse
ESCs (Youngblood et al., 2014 and this manuscript). Similarly,
loss of τCstF-64 resulted in global changes in gene expression in
mouse spermatogenic cells (Li et al., 2012) resulting in male
infertility (Dass et al., 2007; Hockert et al., 2011; Tardif et al.,
2010). These data suggest that loss of CstF-64, such as that of
τCstF-64, will act at one of two levels: (1) it will act directly to
420 B.A. Youngblood, C.C. MacDonaldaffect the expression of key genes through improper 3′ end
processing, or (2) it will act indirectly to affect the expression
of a larger number of genes as consequences of changes in the
first set of genes. In other experiments, we will determine
whether genes involved in the endoderm differentiation
pathway are due to direct or indirect effects, or both, and
what roles CstF-64 and τCstF-64 play in their regulation. From
the data presented here, we know that τCstF-64 can only
partially compensate for the multiple functions of CstF-64,
since the Cstf2E6 cells display a phenotype relative to wild type
ESCs (Youngblood et al., 2014). This suggests that specific gene
targets of CstF-64 and τCstF-64 differ in differentiating ESCs.
Investigation of these targets will help better understand the
pluripotency and differentiation potentials of ESCs, and
advance their therapeutic utility.
Supplementary data to this article can be found online at
http://dx.doi.org/10.1016/j.scr.2014.09.005.Acknowledgments
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